Najnowsze artykuły:
Tak twierdzi zespół naukowców z Uniwersytetu w Cambridge w Wielkiej Brytanii oraz jednostek w Szkocji, USA i na Sri Lance, który przeprowadził badania nad rolą GDF15 w pojawieniu się mdłości i ...
Related: Hyperemesis Gravidarum researcher Dr. Marlena Fejzo is ... genetic risk factor for the disease was a variant of the nausea and vomiting hormone gene GDF15. In a second study, I used an ...
Expression of GDF15 in neonatal cardiomyocyte cultures by adenoviral-mediated gene transfer antagonized agonist-induced hypertrophy in vitro. Transient expression of GDF15 outside the heart by ...
Specific marker genes were identified using the “Find-All-Markers” function with Wilcoxon rank sum test. Anti-CD68 (#66231-2-Ig from Proteintech, Wuhan, Hubei Province, China) and anti-GDF15 (#A0185 ...
In 1999, geneticist Marlena Fejzo had such a bad case of HG that she eventually miscarried—but that didn’t stop her physician from writing off her symptoms as a cry for attention. After she recovered, ...
Diagnosis of hyperemesis gravidarum can be made in the first 16 weeks of pregnancy when a person has nausea and vomiting, at least 1 of which is severe, impairing sufficient intake and affecting tasks ...
Therefore, giving GDF15 to women at risk of hyperemesis gravidarum before conceiving, could mean protecting them from the condition entirely. GDF15, produced at low levels by certain organs ...
Over 20 years ago, during my second pregnancy, I experienced a debilitating case of hyperemesis gravidarum ... of the nausea and vomiting hormone gene GDF15. In a second study, I used an alternate ...
Morning sickness is a bit of a mystery. Why is it that more than two-thirds of pregnant women have attacks of vomiting, particular during the first trimester? And why do some women – famously ...
Note: Before you read this, I would like to say that everyone’s experience of hyperemesis is different, as is everyone’s pregnancy. I had some good and bad advice and I think the challenge is to pick ...
We wish them luck. Instead, our goal is to be the most valuable resource for a specific segment of the industry – cell & gene therapies – and the professionals who make their living there.